Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.83 |
| ▸ | DGKA | P23743 | 1/20 | 0.69 |
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.54 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.54 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.54 |
| ▸ | PAM | P19021 | 2/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8396453 | 1.00 | DNM1 (0.83) | DNM1DGKANAAAPRSS1PRSS2 | |
| SCHEMBL10622058 | 1.00 | DNM1 (0.83) | DNM1DGKANAAAPRSS1PRSS2 | |
| SCHEMBL8398143 | 1.00 | DNM1 (0.83) | DNM1DGKANAAAPRSS1PRSS2 | |
| SCHEMBL6849042 | 1.00 | DNM1 (0.83) | DNM1DGKANAAAPRSS1PRSS2 | |
| SCHEMBL4322849 | 1.00 | DNM1 (0.83) | DNM1DGKANAAAPRSS1PRSS2 | |
| SCHEMBL8394705 | 1.00 | DNM1 (0.83) | DNM1DGKANAAAPRSS1PRSS2 | |
| SCHEMBL4325848 | 1.00 | DNM1 (0.83) | DNM1DGKANAAAPRSS1PRSS2 | |
| SCHEMBL13923753 | 1.00 | DNM1 (0.83) | DNM1DGKANAAAPRSS1PRSS2 | |
| SCHEMBL8397714 | 1.00 | DNM1 (0.83) | DNM1DGKANAAAPRSS1PRSS2 | |
| SCHEMBL1074804 | 0.98 | DNM1 (0.80) | DNM1DGKANAAAPRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4644507-A1 | RUBBER COMPOSITION FOR SEAL MATERIAL | VALQUA, Ltd. (JP) | 2025-11-05 | — | — | EP | disclosed |
| US-20250109277-A1 | CYCLIC OLEFIN RESIN COMPOSITION, MOLDED ARTICLE, AND OPTICAL COMPONENT | MITSUI CHEMICALS, INC. (JP) | 2025-04-03 | — | — | US | disclosed |
| WO-2024142767-A1 | RUBBER COMPOSITION FOR SEAL MATERIAL | 株式会社バルカー | 2024-07-04 | — | — | WO | disclosed |
| WO-2023153302-A1 | CYCLIC OLEFIN RESIN COMPOSITION, MOLDED ARTICLE AND OPTICAL COMPONENT | 三井化学株式会社 | 2023-08-17 | — | — | WO | disclosed |
| CN-107440933-B | Oxidation hair dye composition | 朋友株式会社 | 2023-02-17 | — | — | CN | disclosed |
| CN-107638301-B | First agent for oxidative hair dye and method for stabilizing color tone of oxidative hair dye composition | 朋友株式会社 | 2022-10-14 | — | — | CN | disclosed |
| CN-114796019-A | Composition containing an oxidizing agent | 朋友株式会社 | 2022-07-29 | — | — | CN | disclosed |
| CN-107432837-B | Hair cosmetic composition | 朋友株式会社 | 2022-05-17 | — | — | CN | disclosed |
| CN-107432833-B | Oxidation hair dye composition | 朋友株式会社 | 2022-04-26 | — | — | CN | disclosed |
| US-9487805-B2 | Betaine esters and process for making and using | EASTMAN CHEMICAL COMPANY (US) | 2016-11-08 | — | — | US | disclosed |
| US-20150376662-A1 | BETAINE ESTERS AND PROCESS FOR MAKING AND USING | EASTMAN CHEMICAL COMPANY (US) | 2015-12-31 | — | — | US | disclosed |
| US-20140050687-A1 | BETAINE ESTERS AND PROCESS FOR MAKING AND USING | ESTMAN CHEMICAL COMPANY (US) | 2014-02-20 | — | — | US | disclosed |
| EP-0766691-B1 | HYDROXYALKYLAMMONIUM-PYRIMIDINES OR PURINES AND NUCLEOSIDE DERIVATIVES, USEFUL AS INHIBITORS OF INFLAMMATORY CYTOKINES | MACRONEX INC (US) | 1999-11-10 | — | — | EP | disclosed |
| US-5858472-A | Method of improving the electrical conductivity of a molding article of resin, method of coating a molding article of resin, and coating composition | NIPPON PAINT CO., LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| US-5679684-A | INTIINFLAMMATORY AGENTS, ANTIARTHRITIS AGENTS, NERVOUS SYSTEM DISORDERS, AIDS | MACRONEX, INC. (US) | 1997-10-21 | — | — | US | disclosed |
| EP-0766691-A1 | HYDROXYALKYLAMMONIUM-PYRIMIDINES OR PURINES AND NUCLEOSIDE DERIVATIVES, USEFUL AS INHIBITORS OF INFLAMMATORY CYTOKINES | MACRONEX, INC. (US) | 1997-04-09 | — | — | EP | disclosed |
| EP-0764663-A2 | Method of improving the electrical conductivity of a molding artcile of resin, method of coating a molding article of resin, and coating composition | NIPPON PAINT CO., LTD. (JP) | 1997-03-26 | — | — | EP | disclosed |
| US-5550132-A | TREATING SEPTIC SHOCK, CACHEXIA, RHEUMATOID ARTHRITIS, INFLAMMATORY BOWEL DISEASE, MULTIPLE SCLEROSIS, AIDS | UNIVERSITY OF NORTH CAROLINA (US) | 1996-08-27 | — | — | US | disclosed |
| WO-1995035304-A1 | HYDROXYALKYLAMMONIUM-PYRIMIDINES OR PURINES AND NUCLEOSIDE DERIVATIVES, USEFUL AS INHIBITORS OF INFLAMMATORY CYTOKINES | MACRONEX, INC. (US) | 1995-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140050687-A1 | BETAINE ESTERS AND PROCESS FOR MAKING AND USING | SLC6A12, BCHE, COASY | DNM1 3234/4885DGKA 48/4885NAAA 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.